Cargando…

Dosimetric factors associated with long-term patient-reported outcomes after definitive radiotherapy of patients with head and neck cancer

BACKGROUND: The aim of this study was to explore the relationships between dosimetric parameters of organs at risk and patient-reported outcomes (PRO) after radiotherapy of patients with head and neck cancer. METHODS: PRO data of 53 patients with head and neck cancer treated with radiotherapy were p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayakawa, Toyokazu, Kawakami, Shogo, Soda, Itaru, Kainuma, Takuro, Nozawa, Marika, Sekiguchi, Akane, Miyamoto, Shunsuke, Yamashita, Taku, Ishiyama, Hiromichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902539/ https://www.ncbi.nlm.nih.gov/pubmed/31818301 http://dx.doi.org/10.1186/s13014-019-1429-3

Ejemplares similares

Quality of life score as a prognosticator for pharyngeal cancer patients treated with radiotherapy
por: Ishiyama, Hiromichi, et al.
Publicado: (2022)

Dosimetric Predictors of Toxicity after Prostate Stereotactic Body Radiotherapy: A Single-Institutional Experience of 145 Patients
por: Fujii, Kyohei, et al.
Publicado: (2023)

Catheter displacement prior to the delivery of high-dose-rate brachytherapy in the treatment of prostate cancer patients
por: Kawakami, Shogo, et al.
Publicado: (2014)

(125)Iodine monotherapy for Japanese men with low- and intermediate-risk prostate cancer: outcomes after 5 years of follow-up
por: Sekiguchi, Akane, et al.
Publicado: (2014)

Assessment of transposed ovarian movement: how much of a safety margin should be added during pelvic radiotherapy?
por: Soda, Itaru, et al.
Publicado: (2015)

A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer
por: Kainuma, Takuro, et al.
Publicado: (2019)

Comparison of three different techniques of low-dose-rate seed implantation for prostate cancer
por: Ishiyama, Hiromichi, et al.
Publicado: (2015)

High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up
por: Ishiyama, Hiromichi, et al.
Publicado: (2014)

A cold spot compensation technique using a combination of trans-rectal ultrasonography and intraoperative computed tomography for interstitial permanent prostate brachytherapy: a single-arm prospective trial
por: Ishiyama, Hiromichi, et al.
Publicado: (2018)

Comparison of prostate contours between conventional stepping transverse imaging and Twister-based sagittal imaging in permanent interstitial prostate brachytherapy
por: Kawakami, Shogo, et al.
Publicado: (2017)

Dosimetry of permanent interstitial prostate brachytherapy for an interoperative procedure, using O-arm based CT and TRUS
por: Ishiyama, Hiromichi, et al.
Publicado: (2016)

A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer
por: Kawakami, S., et al.
Publicado: (2022)

Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system
por: Katoh, Norio, et al.
Publicado: (2017)

Perioperative Search for Circulating Tumor Cells in Patients Undergoing Prostate Brachytherapy for Clinically Nonmetastatic Prostate Cancer
por: Tsumura, Hideyasu, et al.
Publicado: (2017)

The Impact of Lymphopenia and Dosimetric Parameters on Overall Survival of Esophageal Cancer Patients Treated with Definitive Radiotherapy
por: Liu, Ming, et al.
Publicado: (2021)

Imaging Cherenkov emission for quality assurance of high-dose-rate brachytherapy
por: Yogo, Katsunori, et al.
Publicado: (2020)

Dosimetric Comparison Study Between Free Breathing and Breath Hold Techniques in Patients Treated by Liver-Directed Stereotactic Body Radiation Therapy
por: Katano, Atsuto, et al.
Publicado: (2023)

Is High Definition MLC Dosimetrically Superior to Standard Definition MLC for SIB-SBRT for Carcinoma Prostate
por: K, Bijina T, et al.
Publicado: (2019)

Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer
por: Tsumura, Hideyasu, et al.
Publicado: (2016)

Dosimetric consequences of the shift towards computed tomography guided target definition and planning for breast conserving radiotherapy
por: van der Laan, Hans Paul, et al.
Publicado: (2008)

Quality of life after definitive linear accelerator-based stereotactic radiotherapy for prostate cancer: a longitudinal study
por: Yamashita, Hideomi, et al.
Publicado: (2022)

Heart Dosimetric Parameters Were Associated With Cardiac Events and Overall Survival for Patients With Locally Advanced Esophageal Cancer Receiving Definitive Radiotherapy
por: Cai, Guoxin, et al.
Publicado: (2020)

Dosimetric impact of target definitions on normal structures in head and neck cancer
por: Monaghan, Micah T, et al.
Publicado: (2011)

Relationship between dosimetric leaf gap and dose calculation errors for high definition multi-leaf collimators in radiotherapy
por: Kim, Jinkoo, et al.
Publicado: (2018)

Cryptococcal osteomyelitis of the Zygomatic bone: a case report
por: Matsuki, Takashi, et al.
Publicado: (2020)

Dosimetric performance of the new high‐definition multileaf collimator for intracranial stereotactic radiosurgery
por: Dhabaan, Anees, et al.
Publicado: (2010)

Physical and dosimetric characteristic of high‐definition multileaf collimator (HDMLC) for SRS and IMRT
por: Sharma, Dayananda Shamurailatpam, et al.
Publicado: (2011)

The impact of emphysema on dosimetric parameters for stereotactic body radiotherapy of the lung
por: Ochiai, Satoru, et al.
Publicado: (2016)

Definitive Radiotherapy for Patients With Anal Squamous Cell Carcinoma: A Retrospective Cohort Study
por: Katano, Atsuto, et al.
Publicado: (2021)

Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study
por: Ariga, Takuro, et al.
Publicado: (2015)

Dosimetric review of cardiac implantable electronic device patients receiving radiotherapy
por: Prisciandaro, Joann I., et al.
Publicado: (2015)

Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non‐small cell lung cancer prior to the approval of durvalumab
por: Fukui, Tomoya, et al.
Publicado: (2020)

Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy
por: Li, Baoqing, et al.
Publicado: (2009)

Clinical and dosimetric risk stratification for patients at high-risk of feeding tube use during definitive IMRT for head and neck cancer
por: Jackson, James E., et al.
Publicado: (2020)

Intraoperative Radiotherapy With INTRABEAM: Technical and Dosimetric Considerations
por: Sethi, Anil, et al.
Publicado: (2018)

Light-Dependent Resistors as Dosimetric Sensors in Radiotherapy
por: Román-Raya, Juan, et al.
Publicado: (2020)

Dosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition case
por: Lobefalo, Francesca, et al.
Publicado: (2013)

Contralateral esophageal sparing technique in definitive radiotherapy for non-small cell lung cancer: dosimetric parameters and normal tissue complication probability modeling
por: Łazar-Poniatowska, Małgorzata, et al.
Publicado: (2022)

Radiation-Induced Emesis (RIE) in Extended-Field Radiotherapy for Gynecological Malignancies: Dosimetric and Non-Dosimetric Factors
por: Wang, Yu-Ming, et al.
Publicado: (2021)

Dosimetric impact of Acuros XB on cervix radiotherapy using RapidArc technique: a dosimetric study
por: Kumar, Lalit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a7do8il75mgq7r3ueirfvukeo2